C.B presents with symptoms confirming a diagnosis of Diabetes Mellitus Type 2. The management of DM involves the incorporation of both pharmacological and non-pharmacological interventions. The pharmacological intervention will involve the initiation of Metformin which is FDA approved as the first-line medication for the management of type 2 diabetes. The drug does not cause weight gain. The patient can also be initiated on HMG-CoA reductase inhibitors, or statins, such as atorvastatin to lower her high cholesterol levels (Serbis et al., 2021). Non-pharmacological interventions will involve nutritional therapy, physical activity programs like yoga or walking, psychological interventions to promote patients’ compliance, social network interventions to promote supportive care, and diabetes self-management education and support for the patient to be able to appropriately monitor her blood sugar levels regularly to enhance treatment outcome.